Stocks in play: Aleafia Health Inc
Announces that it has completed the TSX delisting review and confirms that the Company satisfies the Toronto Stock Exchange’s requirements for continued listing. Aleafia Health will continue to trade on the TSX without further review at this time. Also, five provinces are now selling Aleafia’s adult-use products. Aleafia Health Inc shares T.AH are trading unchanged at $0.07.
Read:
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates
Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America
Fresher, Healthier Food Options Coming Soon to an Airplane Tray Near You
Airline Industry Wooing Back Customers with Enhanced, Healthier Menu Options